Natera, Inc. (NTRA): Price and Financial Metrics

Natera, Inc. (NTRA)

Today's Latest Price: $67.26 USD

1.07 (-1.57%)

Updated Oct 30 4:00pm

Add NTRA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

NTRA Stock Summary

  • NTRA's price/sales ratio is 15.73; that's higher than the P/S ratio of 90.98% of US stocks.
  • With a year-over-year growth in debt of 76.97%, Natera Inc's debt growth rate surpasses 85.22% of about US stocks.
  • As for revenue growth, note that NTRA's revenue has grown 24.95% over the past 12 months; that beats the revenue growth of 82.31% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Natera Inc are TWOU, OMCL, IRTC, EB, and ATRC.
  • NTRA's SEC filings can be seen here. And to visit Natera Inc's official web site, go to

NTRA Stock Price Chart Interactive Chart >

Price chart for NTRA

NTRA Price/Volume Stats

Current price $67.26 52-week high $75.00
Prev. close $68.33 52-week low $16.87
Day low $65.61 Volume 502,600
Day high $69.97 Avg. volume 852,767
50-day MA $67.21 Dividend yield N/A
200-day MA $47.12 Market Cap 5.37B

Natera, Inc. (NTRA) Company Bio

Natera Inc. is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The company was founded in 2003 and is based in San Carlos, California.

NTRA Latest News Stream

Event/Time News Detail
Loading, please wait...

NTRA Latest Social Stream

Loading social stream, please wait...

View Full NTRA Social Stream

Latest NTRA News From Around the Web

Below are the latest news stories about Natera Inc that investors may wish to consider to help them evaluate NTRA as an investment opportunity.

Natera to Present New Gastrointestinal Cancer Data at the ESMO Annual Meeting

SAN CARLOS, Calif., Sept. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized molecular residual disease (MRD) test, Signatera, at the 2020 European Society for Medical…

PR Newswire | September 18, 2020

Natera prices follow-on offering at $60

Natera (NTRA) has priced its public offering of ~4.2M common shares at $60.00/share.Underwriters' over-allotment is an additional ~625K shares.Closing date is September 15.Previously: Natera files for $250M stock offering (Sept. 9)...

Seeking Alpha | September 11, 2020

Natera Announces Pricing of Follow-On Offering

SAN CARLOS, Calif., Sept. 10, 2020 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the pricing of its underwritten public offering of 4,166,666 shares of its common stock at a price to the public of $60.00 per share. Closing of the…

PR Newswire | September 10, 2020

Natera files for $250M stock offering

Natera (NTRA) has filed a preliminary prospectus for a $250M public offering of common stock. Price, volume and terms have yet to be finalized.Shares down 1% after hours....

Seeking Alpha | September 9, 2020

Natera Launches Proposed Follow-On Offering

SAN CARLOS, Calif., Sept. 9, 2020 /PRNewswire/ -- Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $250,000,000 of shares of its common stock. In addition, Natera expects to grant the underwriters…

PR Newswire | September 9, 2020

Read More 'NTRA' Stories Here

NTRA Price Returns

1-mo -7.72%
3-mo 40.07%
6-mo 86.47%
1-year 72.73%
3-year 536.33%
5-year 691.29%
YTD 99.64%
2019 141.33%
2018 55.28%
2017 -23.23%
2016 8.43%
2015 N/A

Continue Researching NTRA

Here are a few links from around the web to help you further your research on Natera Inc's stock as an investment opportunity:

Natera Inc (NTRA) Stock Price | Nasdaq
Natera Inc (NTRA) Stock Quote, History and News - Yahoo Finance
Natera Inc (NTRA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.967 seconds.